Highland Capital Management (Texas)’s Teva Pharmaceuticals TEVA Stock Holding History

Highland Capital Management (Texas)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-175,000	Closed	-$4.26M	–	357
2018 Q2	$4.26M	Buy	+175,000	New	+$3.57M	0.24%	92
2016 Q3	–	Sell	-96,600	Closed	-$4.85M	–	356
2016 Q2	$4.85M	Buy	+96,600	New	+$5.14M	0.2%	118
2016 Q1	–	Sell	-244,490	Closed	-$16M	–	273
2015 Q4	$16M	Buy	+244,490	New	+$15.1M	0.51%	57
2014 Q3	–	Sell	-100,645	Closed	-$5.28M	–	272
2014 Q2	$5.28M	Buy	+100,645	New	+$5.14M	0.19%	94

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Highland Capital Management (Texas)'s TEVA Position: Q3 2018 in Review

Highland Capital Management (Texas) sold out of Teva Pharmaceuticals (TEVA) in Q3 2018, closing a stake of 175,000 shares — an estimated $4.26M sold.

Highland Capital Management (Texas) first reported a position in TEVA in Q2 2014 and held it in 4 quarters. The position peaked at $16M in Q4 2015. 556 funds tracked by Wall St. Rank hold TEVA as of Q3 2018.

Highland Capital Management (Texas) reported no remaining Teva Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Highland Capital Management (Texas) sold 175,000 Teva Pharmaceuticals shares in Q3 2018, an estimated $4.26M.
Highland Capital Management (Texas) first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 4 quarters.
Highland Capital Management (Texas)'s Teva Pharmaceuticals position peaked at $16M in Q4 2015.
556 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2018, filed 14 Nov 2018.